Empagliflozin vs Moxifloxacin
Empagliflozin vs Moxifloxacin: Overview
This comparison examines the pharmacological differences between Empagliflozin and Moxifloxacin.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Moxifloxacin β 12 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Moxifloxacin β C21H24FN3O4.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Moxifloxacin β 401.4350 g/mol.
Type: Empagliflozin β Small molecule; Moxifloxacin β Small molecule.